Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-004337

CFO and CBO acquired 33,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Henderson Molly CFO and CBO 2023-01-19 Grant or award +33,000 78,047 D
Derivatives
Henderson Molly CFO and CBO 2023-01-19 Grant or award · Stock Option (Right to Buy) +55,000 55,000 D
Loading xslF345X03/doc4.xml…